26.5 C
Kuala Lumpur
Friday, September 20, 2019

Tag: Bayer

Bayer shares soars on report of proposed US$8 bil Roundup settlement

Bayer indicates it could pay US$6-US$8 billion but plaintiffs' lawyers want more than US$10 billion to drop the case.

Bayer in frame to win first EU nod for high-precision cancer...

The drug is being recommended for adults and children with difficult to treat forms of cancer that are driven by a rare genetic mutation known as NTRK gene fusion, the European Medicines Agency (EMA) says.

Bayer sells Dr Scholl’s for US$585 mil

The Boston private equity firm Yellow Wood Partners will pay US$585 million for Bayer's Doctor Scholl's business, which generated US$234 million in revenues last year.

Monsanto ordered to pay US$2billion in new Roundup trial

'Instead of investing in sound science, they invested millions in attacking science that threatened their business agenda.'

Bayer apologises for Monsanto PR firm’s media list

Bayer said it had suspended cooperation with the external service provider for now.

Bayer hires law firm to investigate Monsanto stakeholder file issue

The French investigation is the latest fallout from Bayer's US$63 billion takeover of Monsanto.

Bayer jury told US$1 bln roundup award would spur change

Plaintiffs are becoming bolder after winning the first two trials against Bayer.

Investor revolt at Bayer to escalate after CEO keeps his job

More than 55% of shareholders voted that they no longer have confidence in Baumann.

Bayer board backs CEO after unprecedented shareholder rebuke

55.5% of shareholders voted against absolving Baumann of responsibility for their actions in the Monsanto takeover last year.

Bayer, J&J settle thousands of Xarelto lawsuits for US$775 million

Plaintiffs accused the drugmakers of having failed to warn about the bleeding risks.

Bayer faces new marathon after mammoth Monsanto merger

Bayer sold off part of its existing seeds and pesticides businesses to rival BASF to get the Monsanto deal past competition authorities.

French court cancels Monsanto weedkiller permit on safety grounds

A court in Lyon ruled that the approval granted by French environment agency ANSES in 2017 for Roundup Pro 360 failed to take into account potential health risks.

Singer’s Elliott said to build Bayer stake in breakup push

Elliott wants the company’s management and board to evaluate breaking Bayer into separate pharmaceutical and agrochemical makers.

Bayer digs in over glyphosate as thousands of lawsuits loom

Investors have been watching Bayer anxiously as legal risks over the chemical pile up for seeds and pesticides maker Monsanto, which by the end of October faced some 9,300 cases over glyphosate alone.

US judge affirms Monsanto weed-killer verdict, slashes damages

Bayer, which bought Monsanto this year for US$63 billion, says decades of scientific studies and real-world use have shown glyphosate to be safe for human use.

Bayer shares soar as US court reviews cancer ruling

With thousands of other cancer patients' cases against Monsanto pending in the US, the size of the ruling spooked investors, and shares in Bayer are still down 23.6% since January.

Bayer gets new trial on punitive damages in US$289 million weed-killer...

Bayer, which bought Monsanto earlier this year for US$63 billion, faces more than 8,000 similar lawsuits in the United States.

Bayer’s Monsanto faces broad US glyphosate litigation

ZURICH: Bayer AG's Monsanto unit has urged a California judge to toss the $289-million verdict a jury awarded to a man who said the...

Bayer profits plunge as Monsanto buyout bites

The group's crop science unit is set to overtake pharmaceuticals as its biggest sales generator, although prescription medicines command a higher profit margin.

World still needs pesticides, despite Monsanto verdict

Glyphosate remains the world’s most popular and widely used weedkiller - alternatives are nastier chemicals which creates a host of environmental problems.

Bayer shares slide after Monsanto loses verdict in Roundup cancer trial

The trial was an important test of the evidence against Monsanto and will serve as a template for litigating thousands of other claims over the herbicide.

Bayer to withdraw Essure contraceptive implants in US

German chemicals and pharmaceuticals giant, Bayer, will withdraw its controversial Essure contraceptive implants from sale in the United States.

Bayer sees Brazil as key growth driver for global crop division

Brazil is set to become Bayer's main driver of growth and its second-largest market.

Bayer-Monsanto merger creates agrichemical juggernaut

Executives are betting big on projections that around 10 billion people will live on Earth by 2050, meaning more food must grow on the same amount of arable land.